SCHEMBL14725754

SCHEMBL14725754

c1ccc2c(-c3cc4cc5c(cc(-c6cncc7ccccc67)c6c5ccc5c7ccccc7sc56)cc4c4ccc5c6ccccc6sc5c34)cncc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 12/20 0.39
CYP11B1 P15538 10/20 0.39
PRKCZ Q05513 1/20 0.38
CYP17A1 P05093 3/20 0.38
CYP3A4 P08684 2/20 0.38
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX5 P09917 1/20 0.35
ERN1 O75460 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KCNA5 P22460 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725647 0.90 CYP11B2 (0.39) CYP11B2CYP11B1PRKCZCYP17A1CYP3A4
SCHEMBL14725767 0.80 ALOX5 (0.49) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL14725756 0.78 CYP11B1 (0.50) CYP11B2CYP11B1CYP17A1RAB9AALOX5
SCHEMBL14725746 0.77 TNKS (0.42) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL14725753 0.77 CYP11B2 (0.40) CYP11B2CYP11B1PRKCZCYP17A1CYP3A4
SCHEMBL14725758 0.77 ALOX5 (0.37) MAPTCYP2C9ALDH1A1HPGDRAB9A
SCHEMBL14725725 0.75 CYP11B2 (0.38) CYP11B2CYP11B1PRKCZCYP17A1CYP3A4
SCHEMBL14725750 0.75 NPC1 (0.39) MAPTRAB9ASMN1; SMN2ALOX5ATM
SCHEMBL14725748 0.75 CYP11B1 (0.44) CYP11B2CYP11B1CYP17A1CYP3A4CYP1A2
SCHEMBL14725770 0.74 ALOX5 (0.46) MAPTCYP1A2ALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 CYP11B2 836/4885CYP11B1 887/4885PRKCZ 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.